Abstract
Trapped Schistosoma mansoni eggs trigger fibrotic liver disease that can continue to liver cirrhosis and failure. This work evaluates the outcome of platelet rich plasma (PRP) on S. mansoni-induced liver fibrosis by intraperitoneal (IP) and intrahepatic (IH) routes with/without Praziquantel (PZQ) treatment. Swiss albino mice (n = 162) were divided into non-infected (n = 66) and infected (n = 96) groups, then subdivided into non-treated and treated subgroups with PRP(IP), PRP(IH) 6th and 10th weeks post-infection, PZQ, PZQ + PRP(IP) and PZQ + PRP(IH) 6th and 10th weeks post-infection. Effects of treatments were evaluated by parasitological, histopathological and Immunohistochemical assessments. In the early assessment (12th week post-infection) of infected-treated groups, the mean granuloma number showed significant reduction in groups treated with PZQ + PRP (IH) 10th week, PRP (IP), PZQ + PRP (IP) and PZQ + PRP (IH) 6th week (33.33%, 33%, 27.77% and 27.22%, respectively). Furthermore, the mean granuloma diameter showed significant reduction in groups treated with PRP (IH) 10th week and PZQ + PRP (IP) (24.17% and 15.5%, respectively). Also, the fibrotic index showed significant reduction in groups treated with PZQ + PRP (IP), PRP (IP) and PZQ + PRP (IH) 6th week (48.18%, 46.81% and 41.36%, respectively). Transforming growth factor β1(TGF-β1) expression was in correlation with parasitological and histopathological results. Diminished TGF-β1 expression was mostly in infected groups treated with PZQ + PRP (IP), PZQ + PRP (IH) 6th week and PRP (IP) (88.63%, 88.63% and 77.27%, respectively). In the late assessment (14th week post-infection) of infected treated groups, TGF-β1expression was reduced in groups treated with PZQ, PRP (IH) 10th weeks, PRP (IP) (83.33%, 66.66%, 33.33% respectively). PRP showed promising anti-fibrotic effects on S. mansoni-induced liver fibrosis.
Similar content being viewed by others
References
Abd Allah MH, Zaalouk TK, Abo-Sheishaa GA, Shalash IR, Bayoumy AS (2022) Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice. Egypt J Immunol 29(4):174–183
Abd Elzaher F, Moussa M, Raafat M, Emara M (2021) Histological effect of platelet rich plasma on CCL4 induced liver fibrosis in adult albino rat. Egypt J Histol 44(4):932–940
Ahmed SU, Zair M, Chen K, Iu M, He F, Adeyi O, Cleary SP, Ghanekar A (2013) Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice. J vis Exp 79:e50544
Ali S, Hamed M (2006) Effect of Ailanthus altissima and Zizyphus spina-christi on bilharzial infestation in mice, histological and histopathological studies. J Appl Sci 6(7):1437–1446
Alves R, Grimalt R (2018) A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disorders 4(1):18–24
Amaral KB, Silva TP, Dias FF, Malta KK, Rosa FM, Costa-Neto SF (2017) Histological assessment of granulomas in natural and experimental Schistosoma mansoni infections using whole slide imaging. PLoS ONE 12(9):e0184696
Amin MM, Hafez EN, Marei ES (2015) Immunohistochemical studies in mice liver immunized by attenuated Schistosoma mansoni schistosomules by Gamma Radiation. Egypt J Hosp Med 61:406–414
Bos-Mikich A, de Oliveira R, Frantz N (2018) Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet 35(5):753–756
Burke ML, McManus DP, Ramm GA, Duke M, Li Y, Jones MK (2010) Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl Trop Dis 4:e598
Chiaramonte G, Cheever AW, Malley JD, Donaldson DD, Wynn TA (2001) Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 34:273–282
Eissa MM, El-Azzouni MZ, El-Khordagui LK, Abdel Bary A, El-Moslemany RM, Abdel Salam SA (2020) Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni. Acta Trop 212:105714
Eissa FMA, Eassa AHA, Zalat RS, Negm MS, Elmallawany MA (2022) Potential therapeutic effect of platelet-rich plasma and albendazole on the muscular phase of experimental Trichinella spiralis infection. Food Waterborne Parasitol 28:e00180
El-Aswad BEDW, Samar A, Mohamed AH, Shereen FM (2018) Human platelet rich plasma alleviates liver fibrosis in murine Schistosomiasis mansoni. Med J Cairo Univ 86:3807–3823
El-Kholy W, Elgohary S, El Kholy A, El-Ashkar A (2021) The efficacy of platelet rich plasma as adjuvant therapy in the treatment of cryptosporidiosis in experimentally infected immunosuppressed rats. Parasitol United J 14(2):162–170
El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA (2012) Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Parasit Vectors 5(1):1–14
El-Sayed NM, Fathy GM, Abdel-Rahman SAR, El-Shafei MAA (2016) Cytokine patterns in experimental Schistosomiasis mansoni infected mice treated with silymarin. J Parasit Dis 40(3):922–929
Everts P, Onishi K, Jayaram P, Lana JF, Mautner K (2020) Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci 21(20):7794
Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis, resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51:83–88
Feldman AT, Wolfe D (2014) Tissue processing and hematoxylin and eosin staining. Methods Mol Biol (Clifton NJ) 1180:31–43. https://doi.org/10.1007/978-1-4939-1050-2_3
Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-rich plasma. Am J Sports Med 37:2259–2272
Gokkaya A, Gorgu M, Kizilkan J (2019) Our experience regarding withdraw blood from rats and preparation of platelet-rich plasma. Exp Biomed Res 2(1):25–28
Hammam OA, Elkhafif N, Attia YM (2016) Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis. Sci Rep 6(1):21005
Hesami Z, Jamshidzadeh A, Ayatollahi M, Geramizadeh B, Farshad O, Vahdati A (2014) Effect of platelet-rich plasma on CCl4-induced chronic liver injury in male rats. Int J Hepatol. https://doi.org/10.1155/2014/932930
Holanda JC, Pellegrino J, Gazzinelli G (1974) Infection of mice with cercariae and schistosomula of Schistosoma mansoni by intravenous and subcutaneous routes. Rev Jnst Med Trop São Paulo 16:132–134
Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem Off J Histochem Soc 29(4):577–580. https://doi.org/10.1177/29.4.6166661
Kamel MM, El Baz HG, Demerdash Z, Hassan S, Salah F, Mansour WA et al (2018) Cord blood-derived mesenchymal stem cells with hepatogenic differentiation potential ameliorate chronic liver affection in experimental models. Adv Clin Exp Med 27(10):1329–1339
Lamberton PH, Faust CL, Webster JP (2017) Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study. Infect Dis Poverty 6:1–11
Liang YS, Bruce JI and Botd DA (1987) In: Proceeding of the first Sino- American symposium, vol 1, pp. 34–48
Llanwarne F, Helmby H (2020) Granuloma formation and tissue pathology in Schistosoma japonicum versus Schistosoma mansoni infections. Parasite Immunol 43:e12778
LoVerde PT (2019) Schistosomiasis. Adv Exp Med Biol 1154:45–70
Massony P (1929) Some histological methods. Trichrome stain and preliminary technique. Bull Inten Ass Med 7:12–75
Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A (2021) Till death do us part-the multifaceted role of platelets in liver diseases. Int J Mol Sci 22(6):3113
Niu X, Hu T, Hong Y, Li X, Shen Y (2022) The role of praziquantel in the prevention and treatment of fibrosis associated with schistosomiasis: a review. J Trop Med. https://doi.org/10.1155/2022/1413711
Nono JK, Fu K, Mpotje T, Varrone G, Aziz NA, Mosala P, Brombacher F (2020) Investigating the antifibrotic effect of the antiparasitic drug Praziquantel in in vitro and in vivo preclinical models. Sci Rep 10(1):1–12
Ott RL, Longnecker MT (2015) An introduction to statistical methods and data analysis. Cengage Learning
Pavlovic V, Ciric M, Jovanovic V, Stojanovic P (2016) Platelet rich plasma: a short overview of certain bioactive components. Open Med 11:242–247
Pearce EJ, MacDonald AS (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2:499–511
Salem NA, Hamza A, Alnahdi H, Ayaz N (2018) Biochemical and molecular mechanisms of platelet-rich plasma in ameliorating liver fibrosis induced by Dimethylnitrosurea. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 47(6):2331–2339
Shaik J, Farah R and Hordinsky M (2021) Platelet-rich plasma in dermatologic practice. In: Chapter 1: Biology of platelet-rich plasma. Springer, ISBN 978-3-030-66230-1 (eBook)
Shimizu S (2004) The laboratory mouse. Chapter32: Routes of administration. Elsevier, ISBN 0-1233-6425-6
Shoeib HM, Keshk WA, Foda AM, Abo El Noeman SEAE (2018) A study on the regenerative effect of platelet-rich plasma on experimentally induced hepatic damage in albino rats. Can J Physiol Pharmacol 96(6):630–636
Simmons ML and Brick JO (1970) In: A. Hollaender (ed) The laboratory mouse. Prentice-Hall Inc.: Englewood Cliffs, pp. 127–129
Souza D (2020) Platelet-rich plasma. In: Ultrasound for interventional pain management. Springer: Cham, pp. 317–324
Takahashi K, Murata S, Fukunaga K, Ohkohchi N (2013) Human platelets inhibit liver fibrosis in severe combined immunodeficiency mice. World J Gastroenterol 19:525–5260
Tsai WC, Yu TY, Chang GJ, Lin LP, Lin MS, Pang JHS (2018) Platelet-rich plasma releasate promotes regeneration and decreases inflammation and apoptosis of injured skeletal muscle. Am J Sports Med 46(8):1980–1986
Warren KS, Grove DI, Pelley RP (1978) The Schistosoma japonicum egg granuloma. II. Cellular composition, granuloma size, and immunologic concomitants. Am J Trop Med Hyg 27(2):271–275. https://doi.org/10.4269/ajtmh.1978.27.271
Watanabe M, Murata S, Hashimoto I, Na-Kano Y, Ikeda O, Aoyagi Y et al (2009) Platelets contribute to the reduction of liver fibrosis in mice. J Gastroenterol Hepatol 24(1):78–89
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All manuscript authors participated to every activity of it, research idea and design, research methods, writing the article and reviewing it. All authors contributed to the study conception and design. Material preparation, data collection and analysis. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors do not have any competing interests.
Ethics approval
This study was granted by the research ethics committee (REC) for human and animal research, Faculty of Medicine, Cairo University (Code: MD-204-2022).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bayoumi, A.M.A., Ismail, M.A.M., Mahmoud, S.S. et al. The potential curative and hepatoprotective effects of platelet rich plasma on liver fibrosis in Schistosoma mansoni experimentally infected mice. J Parasit Dis 47, 349–362 (2023). https://doi.org/10.1007/s12639-023-01576-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12639-023-01576-9